stockrowMolina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024.
- Revenue
- −3.44%
- EPS
- −51.7%
- Free cash flow
- −20.3%
- Total debt
- +2.54%
Quarter to September 2026, against a year earlier
Follow MOH
Alert me
Molina Healthcare, Inc (MOH) Net income
Molina Healthcare, Inc's net income for fiscal 2025 was $472.0M, down 60.0% from $1.2B in fiscal 2024. Over the twelve months to 30 September 2026 it was −$48.0M. Over the past ten years it has ranged from −$512.0M (fiscal 2017) to $1.2B (fiscal 2024); the current reading is higher than 36% of that period. Molina Healthcare, Inc ranks 12th of 12 Healthcare Plans companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $472.0M | (59.97%) |
| FY2024 | $1.2B | 8.07% |
| FY2023 | $1.1B | 37.75% |
| FY2022 | $792.0M | 20.18% |
| FY2021 | $659.0M | (2.08%) |
| FY2020 | $673.0M | (8.68%) |
| FY2019 | $737.0M | 4.24% |
| FY2018 | $707.0M | — |
| FY2017 | −$512.0M | — |
| FY2016 | $52.0M | (63.64%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $38.0M | (36.67%) |
| Jun 2026 | $60.0M | 328.57% |
| Mar 2026 | $14.0M | — |
| Dec 2025 | −$160.0M | — |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| CI Cigna Group compare | $6.7B |
| ELV Elevance Health, Inc. compare | $5.1B |
| CNC Centene Corporation compare | $1.5B |
| HUM Humana Inc. compare | $1.3B |
| OSCR Oscar Health, Inc. compare | $855.7M |
| PGNY Progyny, Inc. compare | $91.0M |
| ALHC Alignment Healthcare, Inc. compare | $28.9M |
| CLOV Clover Health Investments, Corp. compare | $12.5M |
| MOH Molina Healthcare, Inc | −$48.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on MOH
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement